Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6,768,178
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
5,466,339
-
Shares change
-
+3,086,827
-
Total reported value, excl. options
-
$105,116,648
-
Value change
-
+$61,166,102
-
Number of buys
-
41
-
Number of sells
-
-12
-
Price
-
$19.26
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q1 2021
61 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q1 2021.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,466,339 shares
of 6,768,178 outstanding shares and own 80.77% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (750,194 shares), Farallon Capital Management, L.L.C. (600,000 shares), L1 Capital Pty Ltd (515,222 shares), PURA VIDA INVESTMENTS, LLC (374,707 shares), PERCEPTIVE ADVISORS LLC (327,869 shares), Endurant Capital Management LP (317,876 shares), Maven Securities LTD (313,204 shares), Collaborative Holdings Management LP (281,000 shares), ARK Investment Management LLC (271,619 shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (234,192 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.